CLINICAL EXPERIENCE IN THE TREATMENT OF CARDIOMYOPATHY
The article reviews the expediency of conducting additional studies (chest x-ray, electrocardiogram, echocardiogram) for specification of the diagnosis and efficiency of complex treatment of hypertrophic cardiomyopathy cat drugs (Charter, diltiazem, diver and Mexidol) selected on the basis of the clinical status of the animal. In order to restore cardio-vascular system functions we selected drugs (Charter, diltiazem, diver and Mexidol) and tested their efficiency during HTCM of the cat. Treatment caused positive effects in the animal’s condition and prevented further development of cardiac failure.